Seoul, South Korea

Hea Soon Shin


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Seoul Pharm. Co., Ltd.
 patent
silverMedal1 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hea Soon Shin: Innovator in Hepatic Disease Treatment

Introduction

Hea Soon Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating hepatic diseases. His innovative work has garnered attention for its potential impact on human health.

Latest Patents

Hea Soon Shin holds a patent for "Allylthiopyridazine derivatives and process for preparing the same." This invention relates to a novel allylthiopyridazine derivative represented by a specific formula, which exhibits superior effects for the prevention and treatment of hepatic diseases induced by toxic substances. The compound also offers protection for human tissues from radiation, showcasing its therapeutic potential.

Career Highlights

Throughout his career, Hea Soon Shin has worked with various organizations, including Seoul Pharm Co., Ltd. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in drug development. His work has contributed to advancements in treatments for serious health conditions.

Collaborations

Hea Soon Shin has collaborated with esteemed colleagues, including Soon Kyoung Kwon and Sang Geon Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Hea Soon Shin's contributions to the field of pharmaceuticals, particularly through his patent on allylthiopyridazine derivatives, highlight his role as an innovator in the treatment of hepatic diseases. His work continues to inspire advancements in medical research and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…